Company intelligence / Profile preview

EastBridge Investment

Seoul, South Korea

Ownership: Private
Development stage: Other

Overview

EastBridge Investment appears to be a private equity and family investment entity (primarily referenced as Eastbridge Group/Partners) with investments spanning multiple sectors including biotechnology, but it is not itself a life science/biotech/pharma operating company. No clinical pipeline, therapeutic programs, or healthcare-specific operations identified; health relevance stems from investment portfolio. Active with offices in Seoul, Luxembourg, and New York. UK entity EASTBRIDGE INVESTMENT LIMITED confirmed via Companies House.

Industry: Investors

Beyond the preview

Go deeper on EastBridge Investment.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EastBridge Investment.

Explore the full profile